US levloan feels pricing pain, but balance of power intact

Pricing for European companies like Armacell and Altice marketing leveraged loans in the US has soared in the turmoil following the Fed’s signal on tapering QE, writes Olivier Holmey. But while deals in the less ramped up European market were largely unscathed, few bankers expect the setback to change the longer term appeal of either sector — especially with European CLOs under regulatory pressure.

  • By Olivier Holmey
  • 27 Jun 2013

German foam manufacturer Armacell saw the margins on its facility pushed up by up to 100bp. Dollar pricing for Luxembourg telecoms investment firm Altice rose around 50bp. 

Bankers close to the deals blamed the rises on market volatility following comments by Fed chairman Ben Bernanke, last Wednesday. He ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 7,026 25 11.95
2 Citi 6,449 21 10.96
3 BNP Paribas 5,093 18 8.66
4 Barclays 4,040 11 6.87
5 Lloyds Bank 3,615 14 6.15

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 118,624.20 342 12.90%
2 Bank of America Merrill Lynch 99,769.11 286 10.85%
3 Wells Fargo Securities 87,449.35 261 9.51%
4 JPMorgan 67,955.87 206 7.39%
5 Credit Suisse 50,788.13 152 5.52%